Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ROHTO PHARMACEUTICAL CO LTD amends consolidated full-year outlook for FY 2014


Monday, 12 May 2014 02:00am EDT 

ROHTO PHARMACEUTICAL CO LTD:Says the company amended the consolidated full-year outlook for the FY ended March 2014.Revenue forecast increased to 143,800 million yen from 143,500 million yen.Operating profit forecast decreased to 16,800 million yen from 17,300 million yen.Ordinary profit forecast decreased to 17,100 million yen from 17,400 million yen.Net profit forecast decreased to 9,000 million yen from 11,200 million yen.Earnings per share forecast decreased to 77.15 yen from 98.79 yen.FY 2014 revenues of 143.72 billion yen, reported net profit of 10.95 billion yen – Thomson Reuters I/B/E/S. 

Company Quote

1537.0
19.0 +1.25%
26 Dec 2014